Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Receivables - Net (2010 - 2026)

Vericel (VCEL) posted Receivables - Net of $75.7 million for Q2 2026, up 4.6% sequentially from $72.4 million in Q1 2026, and up 17.77% YoY from $64.3 million in Q2 2025.

Analysis

Vericel (VCEL) Receivables - Net (2010 - 2026) Analysis & Trends

Vericel has reported Receivables - Net for 17 years, with the latest figure at $75.7 million in Q2 2026.

  • Quarterly Receivables - Net rose 17.77% year-over-year to $75.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $75.7 million (up 17.77% YoY) and the FY2025 annual result came in at $84.6 million, up 37.9% from the prior year.
  • Receivables - Net rose to $75.7 million in Q2 2026 per VCEL's latest filing, from $72.4 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $84.6 million in Q4 2025 and troughed at $31.9 million in Q1 2022.
  • A 5-year average of $52.2 million and a median of $49.2 million in 2024 frame the typical range for Receivables - Net.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net increased 5.17% in 2024, then jumped 37.9% in 2025.
  • Over 5 years, Receivables - Net stood at $46.5 million in 2022, then rose by 25.39% to $58.4 million in 2023, then gained by 5.17% to $61.4 million in 2024, then jumped by 37.9% to $84.6 million in 2025, then retreated by 10.54% to $75.7 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $75.7 million, $72.4 million, and $84.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.71 Mn
Mar 31, 2026 72.38 Mn
Dec 31, 2025 84.63 Mn
Sep 30, 2025 60.43 Mn
Jun 30, 2025 64.29 Mn
Mar 31, 2025 52.90 Mn
Dec 31, 2024 61.38 Mn
Sep 30, 2024 48.48 Mn
Jun 30, 2024 48.00 Mn
Mar 31, 2024 49.93 Mn
Dec 31, 2023 58.36 Mn
Sep 30, 2023 39.73 Mn
Jun 30, 2023 38.32 Mn
Mar 31, 2023 38.36 Mn
Dec 31, 2022 46.54 Mn
Sep 30, 2022 34.30 Mn
Jun 30, 2022 33.66 Mn
Mar 31, 2022 31.86 Mn
Dec 31, 2021 37.44 Mn
Sep 30, 2021 28.91 Mn